Healthcare & Life Sciences News and Articles

Google News – NIH External News

Physician-scientist and informatics leader Dr. Peter Embí to helm NIH’s National Library of Medicine - National Institutes of Health (NIH) | (.gov)

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

Shuttle Pharma (SHPH) moves special meeting to Sept. 9 - Stock Titan

news.google.com · 03 Sep 2026

Google News – Clinical Trials External News

Fexofenadine and famotidine lack clinical trial evidence for menopausal symptoms - 2 Minute Medicine

news.google.com · 03 Sep 2026

Google News – Digital Health External News

Digital Experience Crucial for Pharmacies to Drive Patient Retention - drugtopics.com

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

How Rhythm Pharmaceuticals Inc. (RYTM) Affects Rotational Strategy Timing - Stock Traders Daily

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals stock hits 52-week high at $847.60 - Investing.com

news.google.com · 03 Sep 2026

Google News – Biopharma External News

UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy - BioPharma Dive

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Benzinga

news.google.com · 03 Sep 2026

Google News – Biopharma External News

Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts - BioPharma Dive

news.google.com · 03 Sep 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement - TradingKey

news.google.com · 03 Sep 2026

Google News – Biopharma External News

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study - finance.yahoo.com

news.google.com · 02 Sep 2026

Google News – Biopharma External News

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study - Benzinga

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Barchart.com

news.google.com · 02 Sep 2026

Google News – Pharmaceuticals External News

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Yahoo Finance

news.google.com · 02 Sep 2026

Google News – Oncology External News

Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist for Accelerated Discovery in Oncology, Immunology - Contract Pharma

news.google.com · 02 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Physician-scientist and informatics leader Dr. Peter Embí to helm NIH’s National Library of Medicine - National Institutes of Health (NIH) | (.gov)

Shuttle Pharma (SHPH) moves special meeting to Sept. 9 - Stock Titan

Fexofenadine and famotidine lack clinical trial evidence for menopausal symptoms - 2 Minute Medicine

Digital Experience Crucial for Pharmacies to Drive Patient Retention - drugtopics.com

How Rhythm Pharmaceuticals Inc. (RYTM) Affects Rotational Strategy Timing - Stock Traders Daily

Regeneron Pharmaceuticals stock hits 52-week high at $847.60 - Investing.com

UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy - BioPharma Dive

Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years - Benzinga

Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts - BioPharma Dive

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement - TradingKey

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study - finance.yahoo.com

Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study - Benzinga

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Barchart.com

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks? - Yahoo Finance

Boehringer Ingelheim Licenses Owkin’s K Pro AI Scientist for Accelerated Discovery in Oncology, Immunology - Contract Pharma